medigraphic.com
ISSN 1665-2576 (Impreso)

2012, Número 2

<< Anterior Siguiente >>

Rev Mex Cir Endoscop 2012; 13 (2)


Tumor carcinoide de intestino delgado manifestado por abdomen agudo: reporte de un caso

De León AD, Mauricio MH, Cartagena SE, Arribas MA, Cruz RO, Álvarez SM, Ávila GA, Álvarez SZ

Idioma: Español
Referencias bibliográficas: 18
Paginas: 95-101
Archivo PDF: 86.79 Kb.


RESUMEN

Se reporta el caso de un paciente con presencia de tumor carcinoide intestinal que acude a valoración con datos de abdomen agudo, que semejan un cuadro de apendicitis aguda; sin embargo, se realiza estudio exhaustivo de la patología y se realiza diagnóstico y tratamiento de tumor carcinoide.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. American Cancer Society. GI Carcinoid detailed guide, 2011.

  2. Bethesda of Clinical Oncology. Endocrine tumors. 2th ed. Philadelphia: Lippincott Williams and Wilkins, 2005: 454-472.

  3. Coulier B, Pringot J, Gielen I, Maldague P, Broze B, Ramboux A, Clausse M. Carcinoid tumor of the small intestine: MDCT findings with pathologic correlation. JBR-BTR 2007; 90: 507-515.

  4. Wouter WH. Biochemistry of neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab 2007; 21(1): 33-41.

  5. Yantiss RK. Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol 2002; 27: 811-817.

  6. Gill SS, Heuman DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol 2001; 33: 267-282.

  7. Brower ST, Benson AB, Myerson RJ. Carcinoid tumors of the GI tract. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD. Cancer management: a multidisciplinary Approach. 6th ed. PRR, Inc. Melville, NY; 2002: 267-70.

  8. Elizalde I, Borda F. Tratamiento actual del tumor carcinoide. Gastroenterol Hepatol 2002; 25: 508-513.

  9. Kendrick ML, Van Heerden JA. Small bowel carcinoid tumors: current surgical therapy. 7th ed. St Louis: Mosby Press; 2001: 167-70.

  10. Malik AA, Moazzam N, Potti A. Unusual abdominal tumors: small bowel carcinoid presenting as an acute abdomen. J Clin Oncol 2003; 21: 950-951.

  11. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocrine Reviews 2004; 25: 458-511.

  12. Jensen RT, Doherty GM. Carcinoid tumors and the carcinoid syndrome. In: VT DeVita Jr, S Hellman, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia: Lippincott Williams and Wilkins, 2005: 1559-74.

  13. Nobels FR, Kwekkeboom DJ, Coopmans W et al. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Met 1997; 82: 2622-2628.

  14. Baudin E, Gigliotti A, Ducreux M et al. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours. BJ Cancer 1998; 78: 1102-1107.

  15. Bajetta E, Ferrari L, Martinetti A et al. Chromogranin A, neuron specific enolase, carcinoembryonic antigen and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer 1999; 86: 858-865.

  16. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil 2007; 19: 25-31.

  17. Tomassetti P, Migliori M, Caletti GC, Fusaroli P, Corinaldesi R, Gullo L. Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med 2000; 343: 551-554.

  18. Eriksson B, Oberg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion 2000; 62: 33-38.




2020     |     www.medigraphic.com